Nasdaq · Healthcare
Aveanna Healthcare Holdings, Inc. (AVAH)
As-reported financials and recent SEC filings for Aveanna Healthcare Holdings, Inc., latest fiscal period FY2026. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$2.43B
Net income
$225.0M
Net margin
9.2%
Diluted EPS
$1.05
ROE
115.7%
P/E (TTM)
7.2×
Market cap
$1.89B
Debt / equity
6.6×
Income statement (as reported)
| Line | FY2026 | FY2024 | FY2023 | FY2022 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $2.43B | $2.02B | $1.90B | $1.79B | $1.68B |
| Gross profit | — | — | — | — | — |
| Operating income | $256.5M | $139.8M | $8.1M | $-642.3M | $-36.1M |
| Net income | $225.0M | $-10.9M | $-134.5M | $-662.0M | $-117.0M |
| Diluted EPS | $1.05 | $-0.06 | $-0.71 | $-3.57 | $-0.00 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-26
View on EDGAR →42026-06-26
View on EDGAR →42026-06-26
View on EDGAR →1442026-06-24
View on EDGAR →1442026-06-24
View on EDGAR →1442026-06-24
View on EDGAR →42026-06-05
View on EDGAR →42026-06-05
View on EDGAR →Go deeper on AVAH
Search Aveanna Healthcare Holdings, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.